These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 887916)

  • 1. Enzymic activities of commercial preparations of pancreatic enzymes.
    Drummond S; Saunders JH; Leach R; Wormsley KG
    Scott Med J; 1977 Jul; 22(3):221-4. PubMed ID: 887916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro enzyme activities of five commercially available pancreatic supplements.
    Shaw DW; Barbezat GO
    N Z Med J; 1982 Jun; 95(710):424-5. PubMed ID: 6180364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic exocrine insufficiency. IV. The enzyme content of commercial pancreatic supplements.
    Pairent FW; Howard JM
    Arch Surg; 1975 Jun; 110(6):739-41. PubMed ID: 1147772
    [No Abstract]   [Full Text] [Related]  

  • 4. [In-vitro analysis of substances used in pancreozymin substitution therapy].
    Malis F; Fric P
    Arzneimittelforschung; 1974 Apr; 24(4):499-504. PubMed ID: 4408063
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreatic enzymic activities of commercial pancreatic enzyme preparations incubated in human small intestinal juice.
    Ihse I; Lilja P
    Digestion; 1979; 19(1):48-51. PubMed ID: 456768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of pancreatic enzymes used in epidermal separation.
    Omar A; Krebs A
    Arch Dermatol Res (1975); 1975 Sep; 253(2):203-12. PubMed ID: 1238061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of processed Chinese rhubarbs on activities of four digestive enzymes (author's transl)].
    Gao XS
    Zhong Yao Tong Bao; 1981 Sep; 6(5):24-6. PubMed ID: 6176344
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic enzymes--substitution preparations].
    Berndt W
    Z Allgemeinmed; 1972 Dec; 48(35):1641-4. PubMed ID: 4649287
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the possible reason for a recent decline in enzyme activity and efficacy of porcine pancreatic extracts for therapeutic use.
    Allen WM; Patterson DS; Napier DS; Farooqi FA
    J Biol Stand; 1975; 3(3):267-72. PubMed ID: 1158901
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of amylase, lipase and trypsin activities in the preparation Pancreas].
    Kakol H
    Acta Pol Pharm; 1970; 27(5):519. PubMed ID: 5501750
    [No Abstract]   [Full Text] [Related]  

  • 14. Adsorption of enzymes by cell membrane structures (on the example of enterocytes) under normal and pathological conditions.
    Ugolev AM; De Laey P; Iezuitova NN
    Acta Univ Carol Med Monogr; 1977; (77 Pt 1):5-19. PubMed ID: 354357
    [No Abstract]   [Full Text] [Related]  

  • 15. Dissolving a nutrition clog with a new pancreatic enzyme formulation.
    Klang MG; Gandhi UD; Mironova O
    Nutr Clin Pract; 2013 Jun; 28(3):410-2. PubMed ID: 23609477
    [No Abstract]   [Full Text] [Related]  

  • 16. Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation.
    Abello J; Pascaud X; Simoes-Nunes C; Cuber JC; Junien JL; Rozé C
    Pancreas; 1989; 4(5):556-64. PubMed ID: 2478998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the quality of pancreatic preparations: enzyme content, prospective bioavailability, bile acid pattern, and contamination with purines.
    Niessen KH; König J; Molitor M; Neef B
    Eur J Pediatr; 1983 Oct; 141(1):23-9. PubMed ID: 6196198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations.
    Whitehead AM
    Pharm Weekbl Sci; 1988 Feb; 10(1):12-6. PubMed ID: 2451209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titrimetric assay of pancreatic lipase in pharmaceutical preparations.
    Lecat D; Letavernier JF; Bourquin T; Soroste M; Vaucher D
    J Assoc Off Anal Chem; 1986; 69(6):1022-5. PubMed ID: 3804942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.